The collaboration agreement joins Relation’s AI-powered drug discovery platform and human data generation capabilities with ...

Pfizer announced it has entered into an exclusive global collaboration and license agreement with Chongqing Yao ...

Early real-world findings show that Carvykti, a BCMA-directed CAR T-cell therapy, is demonstrating sustained remissions in ...

Carvykti’s emerging Phase III data shows that a single early-line infusion can deliver durable, treatment-free remissions ...

Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...

In today’s Pharmaceutical Executive Daily, the FDA greenlights an expanded use of Breyanzi, Eli Lilly reports Jaypirca met ...

For Phase III trial planning, two suggestions may have merit. Include sizeable subpopulations that payers cannot easily ...

When borders become bottlenecks, leadership—not luck—keeps medicines flowing to the patients that need them. The companies that adapt these new practices will find new opportunities in the changed ...

Scientific advice by EMA. At different stages of your development process, you can go for scientific advice with the EMA. While this service is not free, the associated fees can vary, typically ...

The European pharmaceutical market, representing 20% of the global pharmaceutical market, is not a fortress to be feared but an opportunity to be seized.

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and ...

The agency’s decision is based on claims that the Covid vaccine was linked to the deaths of 10 children.